Impacts of endocrine-disrupting chemicals on prostate function and cancer
Open Access
- 1 March 2022
- journal article
- research article
- Published by Elsevier in Environmental Research
- Vol. 204 (Pt B) , 112085
Abstract
No abstract availableKeywords
Funding Information
- Santé
- Université Laval
- Fondation CHU de Québec
- Canadian Institutes of Health Research
- Natural Sciences and Engineering Research Council of Canada (RGPIN-2015-05413, RGPIN-2019-04740)
This publication has 185 references indexed in Scilit:
- Current concepts and significance of estrogen receptor β in prostate cancerSteroids, 2012
- Adult Murine Prostate Basal and Luminal Cells Are Self-Sustained Lineages that Can Both Serve as Targets for Prostate Cancer InitiationCancer Cell, 2012
- Estrogen receptor β and 17β-hydroxysteroid dehydrogenase type 6, a growth regulatory pathway that is lost in prostate cancerProceedings of the National Academy of Sciences, 2011
- Serum bisphenol A pharmacokinetics and prostate neoplastic responses following oral and subcutaneous exposures in neonatal Sprague–Dawley ratsReproductive Toxicology, 2011
- The pros and cons of phytoestrogensFrontiers in Neuroendocrinology, 2010
- Inhibition of cancer cell invasion and metastasis by genisteinCancer and Metastasis Reviews, 2010
- Isolation, cultivation and characterization of adult murine prostate stem cellsNature Protocols, 2010
- Estrogen receptor–β activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFα mediatedProceedings of the National Academy of Sciences, 2010
- Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletionNature Reviews Endocrinology, 2009
- Combinatorial roles of nuclear receptors in inflammation and immunityNature Reviews Immunology, 2005